MMM. Adolfina Ruiz Martinez

M. Adolfina Ruiz Martinez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


M. Adolfina Ruiz Martinez has a total of 53 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Microencapsulation, Cream Development, and Controlled Clinical Study of an Upcycled Polyphenolic Extract Combined with sh-Oligopeptide-1

    by Teo Mayayo, Gabriella Russo, Ana Leticia Jiménez-Escobar, Noelia Pérez-González, Beatriz Clares, Adolfina Ruiz, Lidia Tomás-Cobos, Ana Valera, Almudena Gómez-Farto, Salvador Arias-Santiago, et al.

    Olive mills produce pomace as a by-product of olive oil production process, which has a negative environmental impact. In this study, the dry extract of pomace (OG2), rich in polyphenols, was used for cosmetic purposes. The polyphenolic extract was encapsulated together with sh-oligopeptide-1 using cellulose fibres by spray-drying technology. Cytotoxicity and antistress cell studies were carried out using a modified cell line (THP1). Based on the results, a single, randomised, self-controlled study was conducted to evaluate the cream in thirty healthy volunteers. Statistical analysis was performed using a paired samples t-test. Skin moisture increased in the treated forearm (p-value < 0.000). There was an increase in elasticity in the treated forearm (p-value 0.042). TEWL decreased after one week of cream application (p-value 0.099). The results of this clinical study showed that the cream improved barrier function after one week of application on healthy skin.

  • Open Access

    Diseño y elaboración de un sérum facial con Lactobacillus fermentum CECT 5716

    by Florina Iulia-Burra, Elena Ortega Martínez, Mª Adolfina Ruiz Martínez, Mª Encarnación Morales Hernández

    Introducción: De todos los órganos del cuerpo, la piel es el que está directa y constantemente expuesto a agentes externos. De ahí la importancia de proporcionarle todos los nutrientes necesarios para mantenerla sana, cuidada e hidratada. Con esta intención se ha diseñado y desarrollado un sérum hidratante con ingredientes activos naturales que incluye una cepa de la especie probiótica Lactobacillus fermentum CECT 5716, como innovación, para potenciar el efecto sinérgico del producto. Método: El producto citado ha sido caracterizado mediante determinaciones de pH, conductividad y viscosidad para probar su estabilidad. Además, se ha estudiado la viabilidad del probiótico y la percepción de los consumidores en estudios de eficacia del producto. Resultados: Los datos extraídos de las mediciones de pH y conductividad aseguran que la aplicación tópica del sérum es segura, al igual que la percepción de eficacia del producto por los consumidores, ofreciendo una mejor apariencia en términos de suavidad y luminosidad. Además, esta investigación ha revelado las características pseudoplásticas del sérum, óptimas para su propósito. Por último, se ha visto que la viabilidad probiótica disminuye con el tiempo. Conclusiones: En base a los resultados obtenidos, se puede afirmar que nuestro sérum hidratante es seguro y eficaz en la hidratación cutánea, debido a las propiedades de las materias primas incorporadas y el mecanismo competitivo de los probióticos incluidos.


  • Open Access

    Biological Implications of a Stroke Therapy Based in Neuroglobin Hyaluronate Nanoparticles. Neuroprotective Role and Molecular Bases

    by María Ángeles Peinado, David Ovelleiro, María Luisa del Moral, Raquel Hernández, Esther Martínez-Lara, Eva Siles, José Rafael Pedrajas, María Luisa García-Martín, Carlos Caro, Sebastián Peralta, et al.

    Exogenous neuroprotective protein neuroglobin (Ngb) cannot cross the blood–brain barrier. To overcome this difficulty, we synthesized hyaluronate nanoparticles (NPs), able to deliver Ngb into the brain in an animal model of stroke (MCAO). These NPs effectively reached neurons, and were microscopically identified after 24 h of reperfusion. Compared to MCAO non-treated animals, those treated with Ngb-NPs showed survival rates up to 50% higher, and better neurological scores. Tissue damage improved with the treatment, but no changes in the infarct volume or in the oxidative/nitrosative values were detected. A proteomics approach (p-value < 0.02; fold change = 0.05) in the infarcted areas showed a total of 219 proteins that significantly changed their expression after stroke and treatment with Ngb-NPs. Of special interest, are proteins such as FBXO7 and NTRK2, which were downexpressed in stroke, but overexpressed after treatment with Ngb-NPs; and ATX2L, which was overexpressed only under the effect of Ngb. Interestingly, the proteins affected by the treatment with Ngb were involved in mitochondrial function and cell death, endocytosis, protein metabolism, cytoskeletal remodeling, or synaptic function, and in regenerative processes, such as dendritogenesis, neuritogenesis, or sinaptogenesis. Consequently, our pharmaceutical preparation may open new therapeutic scopes for stroke and possibly for other neurodegenerative pathologies.


  • Open Access

    Role of proteoglycans on skin ageing: a review

    by M.A. Ruiz Martínez, Sebastián Peralta Galisteo, H. Castán, M.E. Morales Hernández

    This work analyses the role of proteoglycans on skin ageing, influenced by the presence of glycosylated proteins, which exercise diverse functions on the skin. They are essential components that restore the cells, providing hydration, maintaining hydration of the extracellular matrix, preventing the formation of wrinkles thanks to their ability to combine to other molecules such as collagen or hyaluronic acid and favouring the smoothness of the skin texture. The use of these proteins is a very recent and promising topic, since their application may revolutionize skin ageing therapies. Of the existing proteoglycans, decorin, versican and perlecan are of special note, playing a fundamental role on skin.


  • Open Access

    Tú a Harvard y yo a Princenton. De la depresión a la esquizofrenia

    by Mª Adolfina Ruíz Martínez, Sebastián Peralta Galisteo, Herminia Castán Urbano

    Tú a Harvard y yo a Princenton. De la depresión a la esquizofrenia

  • Open Access

    Hyaluronate Nanoparticles as a Delivery System to Carry Neuroglobin to the Brain after Stroke

    by Santos Blanco, Sebastián Peralta, María Encarnación Morales, Esther Martínez-Lara, José Rafael Pedrajas, Herminia Castán, María Ángeles Peinado, María Adolfina Ruiz

    Therapies against stroke can restore the blood supply but cannot prevent the ischemic damage nor stimulate the recovery of the infarcted zone. The neuroglobin protein plays an important role in the neuro-regeneration process after stroke; however, the method for its effective systemic application has not been identified yet, as neuroglobin is unable to pass through the blood-brain barrier. Previously, we developed different types of sodium hyaluronate nanoparticles, which successfully cross the blood-brain barrier after stroke. In this work, these nanoparticles have been used to carry neuroglobin through the bloodstream to the nerve cells in rats submitted to stroke. We have biosynthesized rat-recombinant neuroglobin and determined the formulation of sodium hyaluronate nanoparticles loaded with neuroglobin, as well as its size and ζ-potential, encapsulation efficiently, in vitro release, and its kinetic of liberation. The results show that the formulation achieved is highly compatible with pharmaceutical use and may act as a delivery system to transport neuroglobin within the blood. We have found that this formulation injected intravenously immediately after stroke reached the damaged cerebral parenchyma at early stages (2 h). Neuroglobin colocalizes with its nanocarriers inside the nerve cells and remains after 24 h of reperfusion. In conclusion, the systemic administration of neuroglobin linked to nanoparticles is a potential neuroprotective drug-delivery strategy after stroke episodes.


  • Contribution to determining the antioxidant capacity of melatonin in orodispersible tablets – comparison with reference antioxidants

    by Herminia Muñoz, Sergio García, Adolfina Ruiz

    Melatonin is a hormone used in the treatment of diverse pathologies due to its ability to regulate numerous physiological processes related to biological rhythms and neuroendocrine function. This study examines whether or not the antioxidant capacities of melatonin are modified during the...


  • Silica Nanoparticles: Preparation, Characterization and Applications in Biomedicine

    by M. Encarnación Morales, Herminia Castán, Elena Ortega, M. Adolfina Ruiz


  • Open Access

    Aproximación al tratamiento del envejecimiento cutáneo

    by Mª Adolfina Ruiz Martínez, Mª Encarnación Morales Hernández

    Objectives. Currently the skin aging is very important in the cosmetic field. For this reason, in this work a review about the skin aging is made. Therefore, our work focuses on the different theories that explain the skin aging as well as the causes that can induce this aging. In addition the compounds used in its treatment are studies, both from the point of view of preventive cosmetics as products used as repairmen. Methods. To carry out this work were used different database as the National Library of Medicine, Washington, DC (MEDLINE PubMed) and a lot of interesting information available online. Results. Different compounds are analyzed from a preventive and reparative used. It is observed how the use of many of them can have a dual action, and these compounds can be used with a hydrating and antioxidant purpose moreover the effects taken may be varied and with different intensity. Therefore proteoglycans, hyaluronic acid, peptides, melatonin and DHEA, two hormones recently used, are studied. Among the analyzed antioxidants, vitamin E and polyphenols seem to be more evidence that supporting their beneficial effect. Conclusions. The combination of several cosmetic compounds is a factor to be taken into account. In this sense, the future of anti-aging treatment may depend of a previous genetic study and the development of appropriate formulation for each type of skin. However more studies are needed to substantiate the concept of genocosmetic.